36 Stocks Moving In Friday’s Mid-Day Session
Gainers
Forge Global Holdings, Inc. (NYSE: FRGE) shares jumped 66.4% to $20.70.
Credit Suisse Maintains Neutral on Enfusion, Lowers Price Target to $20
Credit Suisse analyst Kevin Mcveigh maintains Enfusion (NYSE:ENFN) with a Neutral and lowers the price target from $25 to $20.
Enfusion Q4 EPS $(2.26), Sales $31.90M Beat $30.41M Estimate
Enfusion (NYSE:ENFN) reported quarterly losses of $(2.26) per share. The company reported quarterly sales of $31.90 million which beat the analyst consensus estimate of $30.41 million by 4.90 percent.
Earnings Scheduled For March 24, 2022
Companies Reporting Before The Bell
• iHuman (NYSE:IH) is likely to report earnings for its fourth quarter.
Goldman Sachs Maintains Neutral on Enfusion, Lowers Price Target to $15
Goldman Sachs maintains Enfusion (NYSE:ENFN) with a Neutral and lowers the price target from $24 to $15.
Morgan Stanley Maintains Equal-Weight on Enfusion, Lowers Price Target to $22
Morgan Stanley analyst James Faucette maintains Enfusion (NYSE:ENFN) with a Equal-Weight and lowers the price target from $24 to $22.
Enfusion Q3 Sales $29.00M Beat $26.72M Estimate
Enfusion (NYSE:ENFN) reported quarterly sales of $29.00 million which beat the analyst consensus estimate of $26.72 million by 8.53 percent.
Goldman Sachs Initiates Coverage On Enfusion with Neutral Rating, Announces Price Target of $26
Goldman Sachs analyst Gabriela Borges initiates coverage on Enfusion (NYSE:ENFN) with a Neutral rating and announces Price Target of $26.